| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| L C Kopala, W G Hone. Schizophrenia and severe tardive dyskinesia responsive to risperidone. Journal of clinical psychopharmacology. vol 14. issue 6. 1995-04-13. PMID:7533794. |
schizophrenia and severe tardive dyskinesia responsive to risperidone. |
1995-04-13 |
2023-08-12 |
Not clear |
| S Gupta, D W Black, D A Smit. Risperidone: review of its pharmacology and therapeutic use in schizophrenia. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists. vol 6. issue 3. 1995-04-12. PMID:7533585. |
risperidone: review of its pharmacology and therapeutic use in schizophrenia. |
1995-04-12 |
2023-08-12 |
Not clear |
| C Bryoi. [New psychopharmacologic alternatives in treatment of schizophrenia]. Schweizer Archiv fur Neurologie und Psychiatrie (Zurich, Switzerland : 1985). vol 145. issue 6. 1995-04-12. PMID:7533941. |
clozapine, risperidone and remoxipride are three neuroleptics that represent an interesting alternative in the psychopharmacological treatment of schizophrenia. |
1995-04-12 |
2023-08-12 |
Not clear |
| D Keega. Risperidone: neurochemical, pharmacologic and clinical properties of a new antipsychotic drug. Canadian journal of psychiatry. Revue canadienne de psychiatrie. vol 39. issue 9 Suppl 2. 1995-04-06. PMID:7533051. |
in two large-scale trials in north america and europe, risperidone 6 mg and 4 mg to 8 mg/day compared favourably with haloperidol 20 mg or 10 mg/day in controlling the positive symptoms of schizophrenia. |
1995-04-06 |
2023-08-12 |
Not clear |
| D Keega. Risperidone: neurochemical, pharmacologic and clinical properties of a new antipsychotic drug. Canadian journal of psychiatry. Revue canadienne de psychiatrie. vol 39. issue 9 Suppl 2. 1995-04-06. PMID:7533051. |
risperidone would, thus, appear to offer a potential advantage over other neuroleptics, although the place of this new compound in the pharmacological armamentarium of schizophrenia must be clarified in clinical practice. |
1995-04-06 |
2023-08-12 |
Not clear |
| K Kitaichi, K Yamada, T Hasegawa, H Furukawa, T Nabeshim. Effects of risperidone on phencyclidine-induced behaviors: comparison with haloperidol and ritanserin. Japanese journal of pharmacology. vol 66. issue 2. 1995-03-29. PMID:7532732. |
these results suggest that risperidone may have an antipsychotic effect on schizophrenia as well as pcp psychosis in humans by exerting a mixed 5-ht2a/d2 antagonism. |
1995-03-29 |
2023-08-12 |
rat |
| G Chouinard, J L Vainer, M C Bélanger, L Turnier, P Beaudry, J Y Roy, R Mille. Risperidone and clozapine in the treatment of drug-resistant schizophrenia and neuroleptic-induced supersensitivity psychosis. Progress in neuro-psychopharmacology & biological psychiatry. vol 18. issue 7. 1995-03-07. PMID:7531355. |
risperidone and clozapine in the treatment of drug-resistant schizophrenia and neuroleptic-induced supersensitivity psychosis. |
1995-03-07 |
2023-08-12 |
Not clear |
| S Nyberg, L Farde, L Eriksson, C Halldin, B Eriksso. 5-HT2 and D2 dopamine receptor occupancy in the living human brain. A PET study with risperidone. Psychopharmacology. vol 110. issue 3. 1995-02-23. PMID:7530376. |
risperidone is thus an appropriate compound for clinical evaluation of the benefit of combined 5-ht2 and d2 dopamine receptor blockade in the treatment of schizophrenia. |
1995-02-23 |
2023-08-12 |
human |
| S Grant, A Fitto. Risperidone. A review of its pharmacology and therapeutic potential in the treatment of schizophrenia. Drugs. vol 48. issue 2. 1995-01-10. PMID:7527327. |
recent clinical investigation suggests that risperidone is of at least comparable efficacy to haloperidol and perphenazine in improving the symptoms of acute and chronic schizophrenia on short term administration. |
1995-01-10 |
2023-08-12 |
Not clear |
| S Grant, A Fitto. Risperidone. A review of its pharmacology and therapeutic potential in the treatment of schizophrenia. Drugs. vol 48. issue 2. 1995-01-10. PMID:7527327. |
advantages offered by risperidone over haloperidol include a faster onset of antipsychotic action, a lower incidence of extrapyramidal effects and possibly greater efficacy against the negative symptoms of schizophrenia. |
1995-01-10 |
2023-08-12 |
Not clear |
| S Grant, A Fitto. Risperidone. A review of its pharmacology and therapeutic potential in the treatment of schizophrenia. Drugs. vol 48. issue 2. 1995-01-10. PMID:7527327. |
if these benefits prove to be maintained during long term therapy, risperidone is likely to make a significant contribution to the treatment of schizophrenia. |
1995-01-10 |
2023-08-12 |
Not clear |
| L J Cohe. Risperidone. Pharmacotherapy. vol 14. issue 3. 1994-11-21. PMID:7524043. |
clinical trials demonstrate that risperidone is an effective antipsychotic agent that improves negative as well as positive symptoms of schizophrenia. |
1994-11-21 |
2023-08-12 |
Not clear |
| L Kopala, W G Hone. Risperidone, serotonergic mechanisms, and obsessive-compulsive symptoms in schizophrenia. The American journal of psychiatry. vol 151. issue 11. 1994-11-15. PMID:7524373. |
risperidone, serotonergic mechanisms, and obsessive-compulsive symptoms in schizophrenia. |
1994-11-15 |
2023-08-12 |
Not clear |
| J P McEvo. Efficacy of risperidone on positive features of schizophrenia. The Journal of clinical psychiatry. vol 55 Suppl. 1994-09-29. PMID:7520904. |
efficacy of risperidone on positive features of schizophrenia. |
1994-09-29 |
2023-08-12 |
Not clear |
| J P McEvo. Efficacy of risperidone on positive features of schizophrenia. The Journal of clinical psychiatry. vol 55 Suppl. 1994-09-29. PMID:7520904. |
this article describes a subanalysis of a trial of risperidone, a combined 5-ht2a/d2 antagonist, in 513 patients with dsm-iii-r chronic schizophrenia. |
1994-09-29 |
2023-08-12 |
Not clear |
| J P McEvo. Efficacy of risperidone on positive features of schizophrenia. The Journal of clinical psychiatry. vol 55 Suppl. 1994-09-29. PMID:7520904. |
the 6-mg dose of risperidone also produced significantly more improvement than haloperidol 20 mg. we conclude that risperidone is an effective drug for patients with positive features of schizophrenia. |
1994-09-29 |
2023-08-12 |
Not clear |
| N R Schoole. Negative symptoms in schizophrenia: assessment of the effect of risperidone. The Journal of clinical psychiatry. vol 55 Suppl. 1994-09-29. PMID:7520905. |
negative symptoms in schizophrenia: assessment of the effect of risperidone. |
1994-09-29 |
2023-08-12 |
crow |
| H Mok, L N Yatha. Response to clozapine as a predictor of risperidone response in schizophrenia. The American journal of psychiatry. vol 151. issue 9. 1994-09-16. PMID:7520672. |
response to clozapine as a predictor of risperidone response in schizophrenia. |
1994-09-16 |
2023-08-12 |
Not clear |
| J G Edward. Risperidone for schizophrenia. BMJ (Clinical research ed.). vol 308. issue 6940. 1994-07-29. PMID:7517246. |
risperidone for schizophrenia. |
1994-07-29 |
2023-08-12 |
Not clear |
| S R Marder, R C Meibac. Risperidone in the treatment of schizophrenia. The American journal of psychiatry. vol 151. issue 6. 1994-06-15. PMID:7514366. |
risperidone in the treatment of schizophrenia. |
1994-06-15 |
2023-08-12 |
Not clear |